| ontents | ontents | ||||||
|---|---|---|---|---|---|---|---|
| Reference and administrative | information | 1 —2 | |||||
| Statement from the CEO |
3 —4 | ||||||
| Statement from the Chair |
ofTrustees | ||||||
| Governance | 6 —7 | ||||||
| Background and Strategy |
8 —10 | ||||||
| Strategic report —Objectives | &activities | ||||||
| Mountbatten pyramid |
12 —13 | ||||||
| Key Achievements and Performance |
14 | ||||||
| Services across Mountbatten | isle of Wight | and Mountbatten | Hampshire | 15 —24 | |||
| Quality | 25 —35 | ||||||
| Education and Training |
36 —37 | ||||||
| Mandatory training |
38 | ||||||
| Research | 39 | ||||||
| Income generation | 40 —41 | ||||||
| Communications | 42 —44 | ||||||
| Estates and Facilities | 45 —47 | ||||||
| Catenng | 48 | ||||||
| People Services | 49 —54 | ||||||
| Information Technology |
55 —57 | ||||||
| Trustees' duty to promote |
the success of | the Charity —Section 172statement | 58 —60 | ||||
| Sustainabihty and carbon |
reporting | 61 | |||||
| Finanaal review |
62 | ||||||
| Public benefit statement | 63 | ||||||
| Statement oftrustees' responsibilities |
64 | ||||||
| Independent auditor's report |
65 —67 | ||||||
| Consolidated statement of financial |
activities | 68 | |||||
| (incorporating an income |
and | expenditure | account) | ||||
| Balance sheet | 69 | ||||||
| Consolidated statement ofcash flows |
70 | ||||||
| Notes to the financial statements |
71 —97 |
| Bankers: | NatWest | |||||
|---|---|---|---|---|---|---|
| NatWest House |
||||||
| Riverway | ||||||
| Newport | ||||||
| Isle of Wight | ||||||
| PO30 SUX | ||||||
| Investment | Managers: | Brewin Dolphin | (Retired March 2023) | |||
| Vantage Point | ||||||
| Woodwater | Park | |||||
| Pynes Hill |
||||||
| Exeter | ||||||
| EX2 SFD | ||||||
| Investment | Managers: | CCLA Fund | Managers | Ltd | ||
| )appointed | April | 2023) | ||||
| BSQueen | Victona Street | |||||
| London | ||||||
| EC4V 4ET | ||||||
| Investment | Managers: | Ruffer LLP |
(appointed | Apnl 2023) | ||
| 80Victona | Street | |||||
| London | ||||||
| SW1E SIL | ||||||
| Solicitors: | Bates Wells | LLP | ||||
| 10Queen | Street | Place | ||||
| London | ||||||
| EC4R 1BE | ||||||
| Solicitors: | Glanwlles | LLP | ||||
| St Cross Business Park | ||||||
| Newport | ||||||
| Isle of Wight | ||||||
| PO30 SBF | ||||||
| Auditor: | Atets Audit | Services Limited | ||||
| Ashcombe | Court | |||||
| Woolsack | Way | |||||
| Godalming | ||||||
| Surrey | ||||||
| GU7 1LQ |
| 2. | We will meet the needs ofeveryone who requires our care and support, |
We will meet the needs ofeveryone who requires our care and support, |
ensuring that no-one is |
ensuring that no-one is |
ensuring that no-one is |
ignored: | ignored: |
|---|---|---|---|---|---|---|---|
| ~ | Further development of a Children and Young Adults Service in partnership |
with | Kissy Puppy (Isle of | Wight) | and | ||
| Naomi House and Jack's Place (Hampshire) | |||||||
| ~ | A continuation and further development of dementia services and services |
for | older, frail people | ||||
| ~ | Advance Care Planning —continuing to identify people with long term conditions including older people with |
||||||
| frailty | |||||||
| ~ | Health and Social Care Education | ||||||
| ~ | Rapid Palliative Care Discharge Faohtator at Unwersity Hospital Southampton to match the successful |
model | on | ||||
| the Isle of Wight | |||||||
| ~ | Mountbatten Coordmation Centres —24/7 telephone and visiting service across all |
our communities | |||||
| ~ | End of Life Domiciliary Care provision (Continuing Health Care packages) |
||||||
| ~ | New chanty shop model Has been designed to integrate Retail, I-lospitality |
and | Clinical Services | ||||
| 3. | We will make sure that everything Mountbatten offers is sustainable |
for | the | benefit offuture generations: | |||
| ~ | A robust reserves policy and Risk Register |
||||||
| ~ | A Estates task and finish group ensures that our estate is 'fit for purpose' for future |
generations. Two |
Capital | ||||
| Appeals are now planned for the commg year, one for each site |
|||||||
| ~ | A bespoke 'sustainability' strategic implementation plan focusing on fundraising |
and financial resilience | |||||
| ~ | A detailed 'COVID-19' Action and Recovery Plan which has now been fully integrated into our strategic |
plans | |||||
| ~ | A new workforce development plan is in process |
||||||
| ~ | Development of our ongoing education programmes both for our partners |
and | our | local communities | |||
| ~ | A new shops strategy and a growth plan for our Hampshire shops headed up |
by | the | new Head of Retail | Business | ||
| Development and supported by the Retail/shops Advisory Group |
|||||||
| In | order to further support our strategic aims we continue to work m partnership |
for the benefit | of our | local | |||
| communities with examples as follows: |
|||||||
| Isle of Wight NHS Trust Community Paediatric Team |
|||||||
| Kissy Puppy Chanty (The Sophie Rolf Trust) —with a unique Advisory Group |
made up of key stakeholders | ||||||
| Isle ofWight Local Authority |
| Priority 1: Safety | Priority 1: Safety | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Target | How we measure success | |||||||||
| 1.1The implementation | of | All necessary drug formulanes | are built in SystmOne, |
the | ||||||
| electronic | prescnbing | on | the | electronic patient record | ||||||
| Inpatient | Unit at | Mountbatten | Isle | All appropnate employees are |
trained in the use ofthe |
|||||
| ofWight | Hospice | Electronic Prescribing function |
in SystmOne —do we |
need | ||||||
| to explain what this means& | ||||||||||
| Other health professionals, including GP's and community |
||||||||||
| nurses are notified ofthe move to electromc prescribing | in | |||||||||
| SystmOne | ||||||||||
| Electronic Prescnbing module |
in SystmOne goes live. | |||||||||
| 12 Development | of | robust | Pharmacist is in post, has completed an mduction, and |
has | ||||||
| Pharmacy | provision | at | clear objectives set. | |||||||
| Mountbatten Hampshire |
Hospice | Retain and develop links with |
the Royal South Hants | |||||||
| with the | introduction | of | a Band | Ba | Pharmacy service, building links to enable rotational |
staff | ||||
| Speaahst | Pharmacist | role. | exposure to the spemalism of |
palliative care Pharmacy | and | |||||
| provide cover in Band Ba Pharmacist's absence. |
||||||||||
| Develop and agree robust medicines management audit |
||||||||||
| programme working in coniunction with the Medicines |
||||||||||
| Safety and Optimisation team. |
| Tar et | How we measure | success | ||||||
|---|---|---|---|---|---|---|---|---|
| 2.1The | implementation | of | Rehabilitation-led | beds are available and robust |
||||
| rehabilitation-led | beds | on the | procedures are in |
place to inform and support | employees | |||
| Inpatient | Unit at | Mountbatten | Isle | in the provision of patient care | ||||
| ofWight | Hospice | Awareness training |
is provided so employees |
understand | ||||
| why rehabilitation-led beds are appropriate |
at | a particular | ||||||
| stage of patient care | ||||||||
| Training on the processes and procedures is |
provided to | |||||||
| medics and nurses | ||||||||
| Data dashboard in |
place to monitor progress | that is | ||||||
| reported monthly |
at the Quality and Governance |
|||||||
| Committee | ||||||||
| Evaluate and share the outcomes of setting | up | |||||||
| rehabilitation-led | beds with other hospices |
| 2.2 The implementation | 2.2 The implementation | of Nurse- | Mountbatten non-medical prescribing |
education |
|---|---|---|---|---|
| Led beds on | the Inpatient | Unit at | programme is approved by Health Education England |
|
| Mountbatten | Hampshire | Hospice | There is a clinical supervision structure |
in place for |
| Advanced Nurse Prescribers facilitated |
by the Medical | |||
| Team | ||||
| Nurse-led beds expanded from respite |
patients to include | |||
| patients admitted for iron-infusions and step down beds |
||||
| An evaluation ofthe nurse-led bed prolect will be |
||||
| completed and results included m the |
Quahty Report and |
|||
| presented at Quality and Governance |
Committee |
| 3:People's experience | 3:People's experience | 3:People's experience | 3:People's experience | |||
|---|---|---|---|---|---|---|
| Priority 3: People's Experience | ||||||
| Target | How we measure success | |||||
| 3.1Purchase | additional | land on the | Land required to extend the car park has been | |||
| Mountbatten | Isle of Wight | Hospice | site to | purchased | ||
| allow for the | reconfiguration | of car | parking | The Gables and Oak House buildings have been |
||
| which will create increased |
capacity | demolished by an approved contractor |
||||
| Design and layout for the car park has been | ||||||
| approved and shared with staff, volunteers |
and, | |||||
| stakeholders | ||||||
| A robust tender process has been carried out | ||||||
| which meets the requirements ofthe project |
||||||
| and the successful contactor appointed | ||||||
| Extended car park is in use and meets needs | of | |||||
| the service users | ||||||
| 3.2 Refurbishment ofthe Hazel Centre to |
Refurbishment work is completed, |
|||||
| include a new | Cafe and | commercial | Kitchen | commissioned, and signed off, including |
||
| area | compliance registration of fire safety |
|||||
| Redecoration ofthe Hazel Centre communal |
||||||
| areas and refurbishment ofoutdoor areas ofthe |
||||||
| cafe including the purchase of new furniture |
||||||
| Cafe opening hours increased in a staged |
||||||
| approach aiming for opening seven days a |
||||||
| week, including Christmas Day |
||||||
| Feedback from employees, patients and wsitors |
||||||
| regarding their experiences ofthe Cafe |
||||||
| gathered and a report produced. |
| 3 3 Develop | 3 3 Develop | a portfolio of | language | that | staff, | Programme of workshops is in place to discuss |
|
|---|---|---|---|---|---|---|---|
| volunteers | and our community are |
with employees and volunteers about the |
|||||
| comfortable | with using regarding | death, | dying | importance of having a common language about |
|||
| and bereavement | death and dying, which gives them confidence | ||||||
| when speaking to their networks | |||||||
| Mandatory training on the use of a common |
|||||||
| language about death and dying is in place for |
|||||||
| all employees and volunteers |
|||||||
| Employees and volunteers are surveyed to |
|||||||
| assess their understanding ofthe common |
|||||||
| agreed language and the results analysed to |
|||||||
| ensure that it is embedded in the culture |
|||||||
| Plan is in place to communicate our ethos for a |
|||||||
| common language about death and dying both |
|||||||
| internally and to the wider health community |
|||||||
| 3.4 Ensure | Mountbatten's | reach is | wider | and | Develop links across all communities, attending |
||
| equitable | in terms ofaccess to services and | meetings and events where possible within the |
|||||
| suppolt | communities we support |
||||||
| Strengthen links with Homelessness support |
|||||||
| services including misuse of substance services |
|||||||
| and support their development around end-of- |
|||||||
| life care and provision | |||||||
| Build on development ofsupport/information |
|||||||
| clinics within the Hazel Centre and widen the | |||||||
| network | |||||||
| Produce a Equality, diversity and inclusion policy |
|||||||
| Provide teaching sessions for Mountbatten | |||||||
| employees related to the cultural beliefs of all |
|||||||
| community groups and what is important to |
|||||||
| them | |||||||
| Develop a procedure to support staff when |
|||||||
| caring for members ofany under-represented | |||||||
| gl'oup | |||||||
| Explore opportunities to utilise the Hazel Centre |
|||||||
| for diverse means |
| Overall rating for this service | Overall rating for this service | oviiwilulhc | |
|---|---|---|---|
| u ize wzrzx | wfrz | iN~ | ~ |
| liui rierwe | vilvriive i | sow | ~ |
| 1st Awfl.. | zxzrz | ootu~wx | |
| nizvwr»ze | errwnuw& | duu~lw | 0 |
| li I,"4 wzv iv | rri Ilxn | ixnnawiw | rz |
| Mountbatten | Isle ofWight | Isle ofWight | |||
|---|---|---|---|---|---|
| Media/Sites | Vacancies | Applications | Hits | ||
| NHS Jobs | 47 | 517 | 31,232 | ||
| Indeed | 40 | 378 | 47,512 | ||
| IOW jobs | 17 | 72 | 4,868 | ||
| Other Platforms | 40 | 2,152 | |||
| Mountbatten | Hampshire | ||||
| Media/Sites | Vacancies | Applications | Hits | ||
| NHS Jobs | 65 | 350 | 52,175 | ||
| Indeed | 65 | 522 | 75,390 | ||
| Other Platforms | 252 | ||||
| Mountbatten | Group | ||||
| Media/Sites | Vacancies | Applications | Hits | ||
| NHS Jobs | 112 | 867 | 83,407 | ||
| Indeed | 105 | 900 | 122,902 | ||
| IOW Jobs | 17 | 72 | 4,868 | ||
| Other Platforms | 41 | 2,404 |
| Our Workforce | ||
|---|---|---|
| As an organization, we |
are only as strong as | We communicate with our staff in many different ways We |
| the people we' re made | up of. We pride | run an ongoing series ofgeneral open meetings to which all |
| ourselves on the ability |
to recruit, develop, | staff are invited and at which any member ofstaff my raise |
| support and train he best people in each area |
any issue or concern that they may have. | |
| of our work. In order to do this, we need to listen to our employees and understand what kinds ofsupport, information and development opportunities they want to see from us. |
We also have a policy whereby all staff are able to have regular and frequent one to one meetings with their line manager to discuss matters that relate directly to their day to day work or how their work is affecting their day to day life. |
|
| We have a formal annual process of appraisal to formally |
||
| record the performance, development progress and ambitions |
||
| and future plans for the employee and the Chanty. |
||
| Finally, we have a formal process of whistleblowing and an |
||
| identified whistleblowing 'champion' to faalitate swift |
||
| disclosure and resolution to employment, and other, issues |
||
| which may be sensitive, difficult or contentious in nature. |
||
| Suppliers | ||
| We work with a range | of suppliers but given |
While the nature of our activities means that our largest |
| our location and what | it is that we do, they are | expense is Human Resources we still spend significant |
| mostly local suppliers. | They do range from | amounts with external supphers. We are committed to |
| small independents to |
members of large and |
treating them fairly and ensure that as far as possible we pay |
| sometimes international |
corporate groups. | them promptly and deal with them equitably. We run two |
| We value our relationships with all of our |
creditor payment runs every month to ensure that we are able |
|
| suppliers and try hard to build good |
to pay suppliers promptly and within agreed credit terms. |
|
| relationships with all ofour suppliers. |
| rv la0 r4 |
o 0 |
4l | th O th I 01 vt |
m lh r IU 0 PV |
ID ch I/I Ca IU |
'llo IU IDo m Ol |
IDD Co CO IVo |
rh fa |
m m Ol r ID IO |
00 14 ID hl |
o fa Itl ca |
IVo fx IU |
IV Ol IU |
Ol Ol CO VVfa |
C Cla0 V |
||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Vl0 | |||||||||||||||||||||||||||||||
| tU | |||||||||||||||||||||||||||||||
| Cl | |||||||||||||||||||||||||||||||
| '0 | 4/ | Ch | ' | O | m | DN | |||||||||||||||||||||||||
| IUJ Vl Ct |
ID IU 00O Ca m |
Ol '0 41 IV |
Va at |
at fa m Ul m |
o ID m |
C | |||||||||||||||||||||||||
| Ct | |||||||||||||||||||||||||||||||
| E | |||||||||||||||||||||||||||||||
| '0 Cl IJ tU |
4/ | CI m m |
o IO OI co at co |
m41 I IU va |
Dl af ID IU |
oo IO ID Ul co |
IVI mm IO rh |
m CI 41 |
vl'm ID /V |
oO CO ta |
o CI IV |
o 41 CO |
o Ca Ia |
Oo a |
IO ID co Mat |
tU 00 ta 'Cl CJ |
|||||||||||||||
| ta | |||||||||||||||||||||||||||||||
| Cl | |||||||||||||||||||||||||||||||
| 0 | |||||||||||||||||||||||||||||||
| IVO 14 |
0 | 4/ | m IO fa ID la |
m th ht m ao |
ao rh CQ ar |
r o ID m' |
Olo r Ch |
O Ol rh IO |
m /4 m Ul Ol |
Ul t4 r Ol UJ CO |
Co O CJ |
CI CI |
O CI CJ I4 |
m41 CQ 00 rh |
fflh I Co Co m |
Ol CQ faIa |
M IO Mo I/I |
Cl D |
|||||||||||||
| 0 | |||||||||||||||||||||||||||||||
| 10 CJ IJ 4/ |
4l | o o |
ca m 0 tfl m |
' | af tx Ch rv |
m ca Ol |
mo af ID |
O Ifl \0 |
CI' | I at |
CI m |
at M m |
0 C to000 |
||||||||||||||||||
| Ct | |||||||||||||||||||||||||||||||
| C | |||||||||||||||||||||||||||||||
| 0 0VV CI 4I 0 '00 |
'0 Ct IJ Vl 41 C |
W | ID Ct ra Mm IU |
I/1 ra at m ID ca' |
Ca m ca al m H |
00 ID ar /V m' |
r Cho r0 |
mo I/I ID |
m rri th |
m m O co |
oo | ato IO Ch r |
IO ID r ra |
ooo faaf |
ID ID Co |
ID 10 r ra Co rri |
oo | tlo04 CI Qt 00L QI |
|||||||||||||
| 4I | |||||||||||||||||||||||||||||||
| CLx | Ql | ||||||||||||||||||||||||||||||
| Cl lo0 |
0 CI |
||||||||||||||||||||||||||||||
| ta | Cl | ||||||||||||||||||||||||||||||
| E04 | 0 | ra | ra | IVI | Cf | Ul | V Cl |
||||||||||||||||||||||||
| IO0 D 4C N Cl |
C0 N0 lo40 VI 4I NN0 |
O0 100 la |
4 ta tUt0 C C0IJ |
||||||||||||||||||||||||||||
| Cl | CI 4I |
E0 | |||||||||||||||||||||||||||||
| '0 | |||||||||||||||||||||||||||||||
| IJ0 CI Mla IL fa 0 0 4 CI 0 0. E ~ 0 o m QD th D D O O O 4I la lo C 0 41 000 juW |
V0 V 00 CJ 8 0 Eoo 0 C 4I 9 ro E0 C 4 0 C CI U |
IU taU o 0 |
e Io U C 0 U |
CJ 4 000 ro 0 |
0 CI E' S. E E DL Cl fo 0 4 I- IU |
'0 C C 0 |
IU 4 ra CI ro C ta J: U |
CJ loU rc CI C e 0 C |
0 U & C0 E |
CI0 D 0 Cl x Cl 0 |
4I 0 Cl Cl E0IJC 0 '0 0 x 0 IUZ |
0 0 E v . |
C0 E Cl C 0 C 'ar 00 Nal 0 IU Z |
CI 0 41 0 C Cl ~ D 4Itax 4I Z |
0 C |
V C Ctat Cl Jo Cl taC I- |
0 0 O CI Z |
N 'D 0 0 |
lo 0 lat 00 C ra 0 |
0 Cl CIIJ D0 la 0I- |
CI Cl CJ 0 al 0 fa IU 0 |
c CJ E fit ta C 0 tU 0Z |
| The | Group | Earl Mountbatten | Hospice | ||||
|---|---|---|---|---|---|---|---|
| 2023 | 2022 | 2023 | 2022 | ||||
| Note | E | E | |||||
| Fixed assets: | |||||||
| Tangible assets | 12 | 11,693,046 | 11,718,873 | 11,217,448 | 11,282,700 | ||
| Investments | 13 | 31,629 | 7,810,840 | 2 | 5,910,849 | ||
| 11,724,675 | 19,529,713 | 11,217,450 | 17,193,549 | ||||
| Current assets: | |||||||
| Stocks | 9,598 | 2,229 | |||||
| Debtors | 16 | 689,763 | 3,819,692 | 542,822 | 1,922,060 | ||
| Cash at bank and in | hand | 8,884,194 | 1,076,983 | 6,446,730 | 563,622 | ||
| 9,583,555 | 4,898,904 | 6,989,552 | 2,485,682 | ||||
| Liabilities: | |||||||
| Creditors: amounts | falling due within one year | 17 | (2,296,596) | (1,529,446) | (938,949) | (596,973) | |
| Net current assets | 7,286,959 | 3,369,458 | 6,050,603 | 1,888,709 | |||
| Total net assets | 20 | 19,011,634 | 22,899,171 | 17,268,053 | 19,082,258 | ||
| Funds: | |||||||
| Restricted funds | 3,194,784 | 3,221,019 | 3,194,784 | 3,221,019 | |||
| Restricted funds CMH | 220,950 | 239,486 | |||||
| Unrestricted funds: |
|||||||
| Designated funds |
9,573,435 | 9,573.435 | 9,073,435 | 9,073,435 | |||
| General funds | 6,022,465 | 9,865,231 | 4,999,834 | 6,787,804 | |||
| Totalunrestricted | funds | 15,595,900 | 19,438,666 | 14,073,269 | 15,861,239 | ||
| Total funds | 21 | 19,011,634 | 22,899,171 | 17,268,053 | 19,082,258 |
| Note | 2023 | 2022 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| E | E | ||||||||||
| Net cash | provided by |
(used in) operating | |||||||||
| activities | 22 | 613,088 | (351,464) | ||||||||
| Cash flows from investing | activities: | ||||||||||
| Dividends | and interest | 197,097 | 138,425 | ||||||||
| Purchase | of property, | plant and equipment | (361,185) | (535,835) | |||||||
| Proceeds | from disposal | of property, | plant and | ||||||||
| equipment | 26,833 | ||||||||||
| Proceeds | from sale of | investments | 7,190,429 | 1,383,104 | |||||||
| Purchase | of investments | (1,257,072) | (1,689,251) | ||||||||
| Movement in portfolio |
cash held for | investment | 1,424,854 | (793,704) | |||||||
| Net cash | used in investing | activities | 7,194,123 | (1,470,428) | |||||||
| Change in cash and cash equivalents | in the year | 7,807,211 | (1,821,892) | ||||||||
| Cash and | cash equivalents | at the beginmng ofthe |
|||||||||
| year | 1,076,983 | 2,898,875 | |||||||||
| Cash and | cash equivalents | at the end ofthe year | 8,884,194 | 1,076,983 |
| ra raO rc |
ta 0 I- |
W | Irl ID QI mra |
Nl PC I |
Dl r ID 0 |
UI ID m O M |
m ID r |
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | |||||||||||||||||
| ta | C | ||||||||||||||||
| 4I | |||||||||||||||||
| Cl | |||||||||||||||||
| '0 00 |
W | r Ca UI m' |
00 Irt Ct m' |
I/I CQ ID |
4I 4I tU |
Cl V |
|||||||||||
| N Ql |
mm | M | 0 | 00 | |||||||||||||
| CC | |||||||||||||||||
| Cl | |||||||||||||||||
| U ra 40 |
40 0 V |
||||||||||||||||
| 4l | tU | ||||||||||||||||
| 0 | |||||||||||||||||
| 0 | W | M | I/I | ||||||||||||||
| QI V tU |
ID trl O Ql |
DI I CQ ID |
Ql r ID |
ID m O m ID |
ID CQ CI |
IJ 0 |
IU 0 |
||||||||||
| 4 | m | 10C | |||||||||||||||
| o | |||||||||||||||||
| tU | |||||||||||||||||
| m O CC |
0 0 |
w | \0 m Ql |
00 O Ca |
cr ca ID ra f |
rc Dl ra tD ra |
m ID ra ID |
la | 0 L Ql E Ql |
||||||||
| Ct | 0 CIo Cl |
Ia4I E |
|||||||||||||||
| 0 tU IJ Cl CL |
W | m CQ CII |
rMcr CQ |
oo CI Ulla |
o o m |
CQ rn W IU IU CI rc |
IU0 ta Cl 0 IJ fa |
||||||||||
| Ll | fa0 | r | |||||||||||||||
| 0 | Cl | Cl40 | |||||||||||||||
| '0 V N CI L |
VJ | r IQ r M cQ |
rD CQ aa at I |
cr 00 ID ra O I/I |
cc la Ql cc ID rc |
ID cl' rv ra |
CI CI CI Ul CI Dl IN00 |
Xl Ul C 0 IJ Ia IU |
Itl CL |
||||||||
| Z | 0 | ||||||||||||||||
| 0 CI CI |
0 0 Ql |
||||||||||||||||
| CI | IJIJ | ||||||||||||||||
| rc | ta | ||||||||||||||||
| IU | |||||||||||||||||
| Ul | IU IU |
||||||||||||||||
| 10 | |||||||||||||||||
| N Cl |
CI E |
0C IU |
|||||||||||||||
| IJ fa |
ta | ||||||||||||||||
| Oa0 | IU | ||||||||||||||||
| N | ZlC | Cl | |||||||||||||||
| IO 0 |
O E ECo N Nl N C la IN ta —$ la la |
QI C0 la 0 E0 |
U 0. 0Z c 5 |
QtIJ Cl. 0 Z Ct ta Ja 0 |
Cl U 0. 0Z C O |
ClV Cl 0 Z C Cl ta 0 C |
J: Cl 0 Cl IU |
Cl Cl Cl Cl0 Yl |
|||||||||
| QD .—Qa0 4I C la Ia 0 N 4I 4I 0 0 Xzu. |
Cl E0IJC |
CD | fa Ja 0 0 ra UJ |
Qf 0 u |
V Qt |
fa C 0 ra |
Cl tU 0 u |
0 0 0 CI |
IU 0 IU S '3 |
4: Q I/I Cl ta u |
| /0 ruO fu |
0 0 |
w | I/t O' ar Q Mm |
Ol O «f Ol |
IO trt f |
Ol cr fu fu |
Q Q fu |
0 Ctl Ol fu |
mIh r al' fu |
m Cf tu |
Cl | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Iu | Iu | ||||||||||||||||||||
| V u4l |
u/ | Ch m cl' |
IO Ch r cr CO 0 |
th Cf ru r IO fu |
Ih 00O Ct |
Ch IO tu |
OI IO IV O 00 |
||||||||||||||
| CC' | m | ||||||||||||||||||||
| 0 ta V |
W | IO O m Ch 00 /I |
Ol Q Ca m |
rn I/I I tuar |
m I/I ru Cl' ru |
fum | |||||||||||||||
| Ql C |
m | ut | CO | ||||||||||||||||||
| M fuO fu |
0 0 l- |
ul | Ol 0 IO |
m O OI O |
mthfu IO |
CO /4 CO |
|||||||||||||||
| M | h | IXI | CO | ||||||||||||||||||
| ut | CO | CO | |||||||||||||||||||
| IU IJ |
m CI |
mQ | m Cl |
||||||||||||||||||
| Ch Ifl |
Ch m |
m | |||||||||||||||||||
| N | |||||||||||||||||||||
| Ql | |||||||||||||||||||||
| 0 | W | m | m | ||||||||||||||||||
| Ql V |
r CC |
O | tu | CI | |||||||||||||||||
| CC | Ol | M | |||||||||||||||||||
| Ql | M | I/I | |||||||||||||||||||
| 5/ | |||||||||||||||||||||
| N4I | 0. 0 Q |
N Cl |
IUIJ0. 0Z |
||||||||||||||||||
| a0 | |||||||||||||||||||||
| 0e 44O ru v C la fh IQ 0. —5 0 m 0 0 00 —40 IL 0 IU 4ID 00 laDve 0 e 4I O V 0 Xzw |
ClDIa IC V E0 Cl E0VC |
tO CJ I/I Z Z |
0 U ll 0Z C tU ta D C 0 ~ 0 UJ |
ClU CL 0 Z IU fa D C 0 Qt 0 tu |
W I/I Z Z |
0 U '0. I 0Z C Cl ICD C 0 & Ql ut |
01 LI0. 0 Z C Ct fa C Ql C 0 0 CJ |
QtIt Qt 0 v Z '0. C tU 0Z ta Ql C 0 fa 0 D C C 0 nl 0 aC 2 C ct 0 CWtu 0 |
Qt 0 t/ faO IU CI0. 0 fa 0 |
C 0 E 0 CJ Cl V C V 00 5 0 0 0 |
IU .U0. Z C 4I Yll C & Ql Iu |
4l 0! CJ C E E0 El 0 Cl0 I/I |
'8 ClDla Ia IJ E0 4l E0IJ0 IC0 |
'0 Cl 4IIJ 4I tll Cl E0IJC UJ I/IZ |
| ru ruO tu |
e 0 |
ui | m ID tdl ch ID |
Ch IVI m d' |
r id |
ftl r ul 0 |
dr' oi ID Ctl |
ru ruO ru |
td 0 |
w | foal 00 r O |
id ul I/I o |
CQ m m |
||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ru | |||||||||||||||||||||
| '0 4I IJ |
tdl | CO CO |
4' | CI dr |
'0 QlJ |
W | |||||||||||||||
| 4l | rd | Cl | |||||||||||||||||||
| CC | CC | ||||||||||||||||||||
| '0 Cl IJ u Cl |
W | r Ch IQ ul |
r ID ID m |
O CO |
00 ID |
o Cl IU |
ul | m r00 O |
IV ul O m |
dr CQ m |
|||||||||||
| m IVO (4 |
e 0 |
w | \O | d dl' I |
CC ID |
IVI O iu |
0 0 |
W | |||||||||||||
| ru | Ol ID |
rm | |||||||||||||||||||
| 0 Cl |
w | tu CO |
' | iu dr |
tu | 0 Cl |
W | ||||||||||||||
| U | ID | I/I rh |
Ol | tJ | |||||||||||||||||
| fu | A | ||||||||||||||||||||
| 4I | Cl | ||||||||||||||||||||
| 4l IJ u4I 0 |
ui | Ul CO O |
ul I/I CQ dl' ttl |
OI Io Ih ru m |
d 'cr r Ol ID |
m 00 m /Im' |
10 CJ IJ Cl |
W | ID ru dl' O IA |
ID ID |
O r |
||||||||||
| ttl | |||||||||||||||||||||
| CI | |||||||||||||||||||||
| '8 | |||||||||||||||||||||
| OI | |||||||||||||||||||||
| 0e m E lu e O ldC ld th td O'V 2 C + 0 eC4e '0 C 0 4l dl Ow e 0» e 4I 0XZ4 0 0 |
000 10 IC Cl 0 E0 Cl E0IJ0 |
0 IJ 000 dl C |
4J U Q 0 c Cl fll 0 uJ dl |
QlIJ0. 0 Z dl rd C 0 C U 0 |
U C tU 0 C 0 U 0 I/I |
0. 0Z C e td C 0 td UJ |
Cl\J td JQ C N C 0 U |
0V0 | IU C U Cl 6. E e 8 U Z IU 0, 0 0 td C Cl Cl 0 C tl! 0 E0 0 e + c E— 0 td 0 U UJ U C |
| 0 | 0 | Ul | 0 0 d Vl |
ca Ol aa Ul1 |
Do t Ul |
co IIl Ol |
o Ch |
vt 0 UI m |
0 r d Do Itl |
Vl ID |
Da m 0 Vl |
CO lt r |
ca | 0 th Vl rn |
m N O Oo 0 |
d 0 CO Ol |
co I Ul 'd |
co co Ol Ch |
m CO N (1 M |
r N r IO M |
m 0 to th |
m Ch IO |
|||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| (U | O | ||||||||||||||||||||||||||||||||
| m0 | 0 | Ul MO |
N ca |
Ol Ca |
ar Vl 1 (U |
I (U m |
00 (C Ol m |
0 0 0 d r'm 0 d (1 |
m N 0 oi d |
I m 0 |
Ol IO |
Ol ct N Ct |
Ch Ol Ul 0 |
0 I CO |
Vl m IO ID |
Vl r N |
m r Vl ta M |
LD N 0 N |
rh I th 0lt |
rCI CI m |
Cl m |
||||||||||||
| CO | |||||||||||||||||||||||||||||||||
| 0 0 «L |
W | Ch CI \0lt Ul N |
I Ol CO |
ID Ul |
m CI m |
0 r vi m m |
0 r co m |
r «h r ca I |
LD ro |
m I oo |
CD CO m Ol |
o | 0 N m CO |
m ch 0 Io |
|||||||||||||||||||
| IL | |||||||||||||||||||||||||||||||||
| Vl | |||||||||||||||||||||||||||||||||
| Cl 0C cl |
W | M O thI |
' | Ch Ul |
IID Ol |
Ul Ol0 DoN |
\O UI |
||||||||||||||||||||||||||
| 00 | |||||||||||||||||||||||||||||||||
| Dl | E E0V |
Cl V |
UI | rl M |
r CI |
Ch Ch Ch O |
Co O0 ( Vl |
m | Ul r |
O Ci 0 t |
m N |
||||||||||||||||||||||
| V4 | |||||||||||||||||||||||||||||||||
| cl | |||||||||||||||||||||||||||||||||
| JJ | |||||||||||||||||||||||||||||||||
| 4 V |
D 0 Cl |
to V D |
N | 0 m(1 |
Ol m Ct |
co IO (1 IO |
vt m Itl \D |
0 Co te IV |
Vl I IO |
( Ol th CO Ol |
m N 0 N IO |
0 (1 Ol |
d ra |
UI r Ch CO |
UI ID CO CaN O |
||||||||||||||||||
| 4 | |||||||||||||||||||||||||||||||||
| CL0 | |||||||||||||||||||||||||||||||||
| aa Tl 0 |
0 | W | UI CO Vl0 CO (1 |
(1 | Ol m |
Vl 0 r O |
0 0 m |
0 Do m |
m Vl Ol Ch |
0 r |
0tt | rIO0 co |
Ch lo moto oem Ul I Ca DO IO CO Do CO m |
mr tor co (1 |
m m Vl Ol |
Vl mm m |
|||||||||||||||||
| 0V | |||||||||||||||||||||||||||||||||
| la | |||||||||||||||||||||||||||||||||
| or | |||||||||||||||||||||||||||||||||
| C0 | |||||||||||||||||||||||||||||||||
| IJ | |||||||||||||||||||||||||||||||||
| C0 | m | al | |||||||||||||||||||||||||||||||
| E CU 0 0 v Id lo Cn OI a —j C0 m 0 —ZI IL 0 g DID 0 IO III0 ol 0 O XZW |
DIC 4la. X 4I 000 loC |
~I0Z 0 V 0 |
Clo0 00V nt V la CI |
Dl 00a X Cl 0 |
0V Cl 0 .— C E Dlla C D |
.e U ra 0 0 |
0V Cct 0 0 ll |
(D 0 |
Cl Oa4 D E 0 |
Ct 0 C 0 V V4 llC4 0 |
4 C0 ~I 0 Q Cl ao |
0 | tlDc 0 DV |
0 E CI CL |
I0D. 00 0 11 C C0 4 J CI a ID |
Dl U C I |
a E 0 Cl U 0 4C Cl C0 |
00 DU o a C e C 0 Q CV 0 |
d CI 4I 0 al |
ClJl Dl E C0V |
Z UJ 0 0 a Ul |
Z V 0 0 a. Vl |
z 0V Dl UC0C e |
Z 0 U e UC C 4 00 |
Pv NON 4I DD 0 0 I |
CI Cl 14C ~IO. X Cl Ia0 |
| IU O |
«w 0 |
«w 0 |
o Pl O d UI |
co Ch co IO m |
~0 d ln |
lo th 0 I |
r O M Ol |
m UtO Ul |
0 00 Ch |
Ut h 0! |
Co N m 0 Irl |
Co f r N d |
Co N |
lrl m |
Ul O Co O |
cr O 00 0 N |
co lO nr ln |
ao CO Ol cn IU |
m ~0 I m |
N | m O tfUl |
m | m m |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 0 |
mlo CO IO nr |
\0«I 0 O |
cr O Co Ch |
OU! O «I |
N O O |
«I i m |
f Ol |
OI1 | Ol m |
|||||||||||||||||||||||
| O. | ||||||||||||||||||||||||||||||||
| Ul | ||||||||||||||||||||||||||||||||
| Cl V «C |
U | UJ | Co 0 I |
' | CO N i |
IO m I O |
0 m co r |
O O r |
||||||||||||||||||||||||
| Cl | ||||||||||||||||||||||||||||||||
| 0 | ||||||||||||||||||||||||||||||||
| IO | ||||||||||||||||||||||||||||||||
| U | w | m | N nr |
o nr 0 |
r Ln |
m | ||||||||||||||||||||||||||
| I | nr«I | Oi | I m |
m \0 |
||||||||||||||||||||||||||||
| Co | O | Co | r | |||||||||||||||||||||||||||||
| Cl | 0 | rn | ||||||||||||||||||||||||||||||
| U | ||||||||||||||||||||||||||||||||
| nl | ||||||||||||||||||||||||||||||||
| ClDta | ||||||||||||||||||||||||||||||||
| ta | ta CI C 4I |
0 | m r IO |
ra | O N |
IU d Co 4 IO Ul |
nl 0 Ul Oi 0 |
m rh m Ol Co |
UI nrat th |
O O |
tn | Co Co m |
O 0 |
|||||||||||||||||||
| ta | ||||||||||||||||||||||||||||||||
| CL C |
||||||||||||||||||||||||||||||||
| 00 C 0 |
0 | r rn 0th 0 Ol Ul ra |
O r d Co ch |
m | O | O Ul IO O |
r N r lo m |
ao N Cli |
ca r d IO |
r Co r UI |
||||||||||||||||||||||
| 0 | m | m | co | r | ||||||||||||||||||||||||||||
| 0IJ | ||||||||||||||||||||||||||||||||
| lo | ||||||||||||||||||||||||||||||||
| Cl | ||||||||||||||||||||||||||||||||
| 0 | ||||||||||||||||||||||||||||||||
| a | ||||||||||||||||||||||||||||||||
| 0 | ||||||||||||||||||||||||||||||||
| 4l | M | CI | ||||||||||||||||||||||||||||||
| E | 04 | |||||||||||||||||||||||||||||||
| 4I lo lrl CO 04 IJ nl o. —j 0 m IL ClD C 4I D«O 0 0! 4I Cl 2ZW0 |
C Cla« Cl 0 lo |
Cl 0Z o U Ut |
D E C0IJ « U nn |
0 C « Cl 0 |
0 ~I 0 0 E 0 C0 |
Cl I C |
0 000 tl0 0 |
V Cl 0 |
CI E CI 0 00 0 C nl |
V00L I Cl CI « C 0 U |
0C0 ~I0 C 0 C lotn Cl |
0 V |
00 C CI 0 U |
0 E tU tL |
0 4! 0 01! C nl 0 U ta a0 CI |
0 0 nl |
C0 nlV 0 D E a 0 C «nl tU 0 0 0 c a 0c D 2 U |
Cl nl 0 0V 0 |
« a E C0 U |
Z I 0 V 0 a a Ul |
Z U 0 0 a a Ul |
Z 0 V Cl V C 0 C al 0 to |
Z U 0 V 4I U 0 tn L tn 0 |
IU 4 CI ra 4I '00 4Io. IC Cl la0 I |
| This is sta | ted after | char | ging | |||
|---|---|---|---|---|---|---|
| 2023 | 2022 | |||||
| E | E | |||||
| Depreciation | 387,012 | 298,014 | ||||
| Operating | lease rentals: | |||||
| Property - EMH |
199,539 | 196,550 | ||||
| Property - CMH |
147,335 | 109,647 | ||||
| Auditor's | remuneration | (excluding | VAT): | |||
| Audit | - EMH | 24,650 | 22,250 | |||
| Audit | - CMH | 20,600 | 18,750 | |||
| Other | services | - EMH | 1,300 | 1,250 | ||
| Other | services | —CMH | 1,300 | 1,250 |
| Staff costs were as | Staff costs were as | follows: | |||||
|---|---|---|---|---|---|---|---|
| Current year | 2023 | ||||||
| EMH | CMH | Total | |||||
| E | E | E | |||||
| Staff under | service | level agreement | with | NHS | 732,360 | 3,597,801 | 4,330,161 |
| Wages and | salaries | 4,898,863 | 1,308,906 | 6,207,769 | |||
| Employer's | national | insurance | 466,615 | 368,934 | 835,549 | ||
| Pension costs | 545,763 | 419,656 | 965,419 | ||||
| Temporary | and agency staff | 907,991 | 400,014 | 1,308,005 | |||
| Other staff | costs | 333,373 | 223,336 | 556,709 | |||
| 7,884,965 | 6,318,647 | 14,203,612 |
| Prior year | 2022 | ||||||
|---|---|---|---|---|---|---|---|
| EMH | CMH | Tata I |
|||||
| E | E | E | |||||
| Staff under | service | level agreement | with | NHS | 731,585 | 3,079,246 | 3,810,831 |
| Wages and | salaries | 4,351,522 | 1,333,403 | 5,684,925 | |||
| Employer's | national | insurance | 396,510 | 291,71& | 688,228 | ||
| Pension costs | 495,878 | 388,283 | 884,161 | ||||
| Temporary | and agency staff | 745,748 | 268,681 | 1,014,429 | |||
| Other staff | costs | 224,077 | 234,379 | 458,456 | |||
| 6,945,319 | 5,595.710 | 12,541,030 |
| The following number of employees received employee insurance) during the year between: |
benefits (excluding employer pension costs and |
national |
|---|---|---|
| 2023 | 2022 | |
| No. | No. | |
| E60,000 - E69,999 | 1 | 1 |
| E70,000 - E79,999 | 1 | 1 |
| E80,000 —E89,999 | 2 | 1 |
| E90,000 - E99,999 | 1 | 1 |
| E100,000 - E109,999 | 1 | |
| E110,000 - E119,999 |
| 9. St |
aff numbers | ||||
|---|---|---|---|---|---|
| 2023 | 2023 | 2022 | 2022 | ||
| Employed | Recharged | Employed | Recharged | ||
| by Charity | to Charity | by Charity | to Charity | ||
| No. | No. | No. | No. | ||
| Fundraising | - EMH | 11 | 10 | ||
| Fundraising | -CMH | 5 | 32 | ||
| In patient | unit / Patient services - EMH | 68 | 52 | ||
| In patient | unit / Patient serwces - CMH | 79 | 137 | ||
| Community | 107 | 56 | |||
| Day unit / | JCC | 18 | 10 | ||
| Retail | 61 | 4( | |||
| Support | 80 | 43 | |||
| 429 | 381 |
| 12. Tangible fixe |
d assets | |||||
|---|---|---|---|---|---|---|
| Fixtures, | ||||||
| Land and | Leasehold | fittings and | Motor | |||
| Group | buildings | improvements | equipment | vehicles | Total | |
| E | E | E | E | E | ||
| Cost | ||||||
| At the start of the year | 11,112,676 | 250,674 | 2,454,453 | 261,197 | 14,079,000 | |
| Additions in year |
57,433 | 35,858 | 265,394 | 2,500 | 361,185 | |
| Disposals in year |
||||||
| Transfers | (136,940) | 136,940 | ||||
| At the end ofthe year | 11,033,169 | 423,472 | 2,719,847 | 263,697 | 14,440,185 | |
| Depreciation | ||||||
| At the start ofthe year | 153,372 | 43,126 | 1,961,745 | 201,884 | 2,360,127 | |
| Charge for the year | 13,042 | 75,746 | 271,939 | 26,285 | 387,012 | |
| Depreciation ehminated |
on disposal | |||||
| Transfers | (122,951) | 122,951 | ||||
| At the end ofthe year | 43,463 | 241,823 | 2,233,684 | 228,169 | 2,747,139 | |
| Net book value | ||||||
| At the end ofthe year | 10,989,706 | 181,649 | 486,163 | 35,528 | 11,693,046 | |
| At the start ofthe year | 10,959,304 | 207,548 | 492,708 | 59,313 | 11,718,873 | |
| Freehold | Fixtures, | |||||
| land and | Leasehold | fittings and | Motor | |||
| Earl Mountbatten Hospice |
buildings | improvements | equipment | vehicles | Total | |
| E | E | E | E | E | ||
| Cost | ||||||
| At the start ofthe year | 11,062,094 | 2,031,583 | 261,197 | 13,354,874 | ||
| Additions in year |
55,860 | 27,555 | 83,415 | |||
| Disposals in year |
||||||
| Transfers | (136,940) | 136,940 | ||||
| At the end ofthe year | 10,981,014 | 136,940 | 2,059,138 | 261,197 | 13,438,289 | |
| Depreciation | ||||||
| At the start ofthe year | 122,951 | 1,747,339 | 201,884 | 2,072,174 | ||
| Charge for the year | 7,760 | 115,117 | 25,790 | 148,667 | ||
| Depreciation eliminated |
on disposal | |||||
| Transfers | (122,951) | 122,951 | ||||
| At the end ofthe year | 130,711 | 1,862,456 | 227,674 | 2,220,841 | ||
| Net book value | ||||||
| At the end ofthe year | 10,981,014 | 6,229 | 196,682 | 33,523 | 11,217,448 | |
| At the start ofthe year | 10,939,143 | 284,244 | 59,313 | 11,282,700 |
| Group | Earl Mountbatten | Hospice | ||||||
|---|---|---|---|---|---|---|---|---|
| 2023 | 2022 | 2023 | 2022 | |||||
| E | E | E | E | |||||
| Listed investments | ||||||||
| Fair value | at the | start ofthe year | 6,385,986 | 5,794,747 | 4,827,958 | 4,462,912 | ||
| Additions | at cost | 1,257,071 | 1,689,251 | 955,107 | 1,319,277 | |||
| Disposal proceeds | (7,190,428) | (1,383,104) | (5,463,195) | (1,078,776) | ||||
| Net (loss)/gain on change |
in fair value | (421,000) | 285,092 | (319,870) | 124,545 | |||
| 31,629 | 6,385,986 | 4,827,958 | ||||||
| Cash held | by investment | broker pending | ||||||
| reinvestment | 1,424,854 | 1,082,889 | ||||||
| Investment | in group undertaking | |||||||
| Fair value | at the | end ofthe year | 31,629 | 7,810,840 | 2 | 5,910,849 | ||
| 2023 | 2022 | |||||||
| E | E | |||||||
| UK Bonds | 497,542 | |||||||
| Overseas | Bonds | 31,629 | 426,507 | |||||
| UK Equities | 1,662,869 | |||||||
| North American | Equities | 1,560,358 | ||||||
| European | Equities | 407,543 | ||||||
| Japanese | Equities | 220,427 | ||||||
| Asia Pacific Equities | 523,137 | |||||||
| Emerging | Market | Equities | 99,881 | |||||
| Global Investments | 298,476 | |||||||
| Absolute | Return | 208,631 | ||||||
| Property | Trusts | 212,522 | ||||||
| Other | 268,093 | |||||||
| Cash | 1,424,854 | |||||||
| 31,629 | 7,810,840 |
| Countess | ||||||||
|---|---|---|---|---|---|---|---|---|
| Countess | Mountbatten | Earl | ||||||
| Mountbatten | Hospice | Mountbatten | ||||||
| Hospice Charity | Promotions | Hospice Trading | ||||||
| Year ended | 31March 2023 | Limited | l.imited | Limited | ||||
| 6 | E | E | ||||||
| Income/ turnover |
6,968,189 | 402,733 | 104,069 | |||||
| Cost of sales | (131,389) | (8,461) | ||||||
| Net income/ | gross profit | 6,968,189 | 271,344 | 95,608 | ||||
| Net expenditure / |
administratwe | expenses | (9,182,898) | (18,202) | (36,158) | |||
| Distribution | from subsidiary | 482,590 | ||||||
| Loss on investment | assets | (101,130) | ||||||
| Net income/(expenditure)/profit/(loss) | for the financial | |||||||
| year | (1,833,249) | 253,142 | 59,450 | |||||
| Funds/retamed earnings brought |
forward | 3,339,377 | 477,536 | |||||
| Net income/(expenditure)/profit/(loss) | for the financial | |||||||
| year | (1,833,249) | 253,142 | 59,450 | |||||
| Distribution | under | Gift Aid to parent | charity | (482,590) | (59,450) | |||
| Reserves/retained | earnings | carried forward | 1,506,128 | 248,088 | ||||
| The aggregate of the assets, | kabilities | and funds was: | ||||||
| Assets | 2,927,144 | 288,307 | 27,333 | |||||
| Liabilities | (1,421,016) | (40,217) | (27,331) | |||||
| Funds | 1,506,128 | 248,090 |
| Countess | ||||||||
|---|---|---|---|---|---|---|---|---|
| Countess | Mountbatten | Earl | ||||||
| Mountbatten | Hospice | Mountbatten | ||||||
| Hospice Charity | Promotions | Hospice Trading | ||||||
| Year ended 31March 2022 | Limited | Limited | l.imited | |||||
| E | E | E | ||||||
| Income / turnover | 9,335,716 | 373,587 | 78,305 | |||||
| Cost ofsales | (118,092) | (6,699) | ||||||
| Net mcome/gross | profit | 9,335,716 | 255,495 | 71,606 | ||||
| Net expenditure/administratwe | expenses | (8,028,476) | (26,047) | (35,893) | ||||
| Distnbution from |
subsidiary | 57,660 | ||||||
| Gain on investment | assets | 160,547 | ||||||
| Net (expenditure)/profit for |
the | finanmal | year | 1,525,447 | 229,448 | 35,713 | ||
| Funds/retained earnings brought |
forward | 1,813,930 | 305,748 | (2,195) | ||||
| Net income/(expenditure)/profit/(loss) | for the financial year | 1,525,447 | 229,448 | 35,713 | ||||
| Distribution under |
Gift Aid to parent | charity | (57,660) | (33,518) | ||||
| Reserves/retained | earnings | earned forward | 3,339,377 | 477,536 | ||||
| The aggregate ofthe assets, | liabilities | and | funds was: | |||||
| Assets | 4,738,226 | 535,666 | 37,019 | |||||
| Liabilities | (1,398,849) | (58,128) | (37,017) | |||||
| Funds | 3,339,377 | 477,538 |
| 2023 | 2022 | ||
|---|---|---|---|
| E | E | ||
| Gross | income | 8,784,402 | 10,471,563 |
| Result | for the year | (1,814,204) | 1,272,168 |
| 16. | Debtors |
| Group | Earl Mountbatten | Hospice | |||
|---|---|---|---|---|---|
| 2023 | 2022 | 2023 | 2022 | ||
| E | E | E | E | ||
| Amounts | due from group entities | 22,732 | 211,712 | ||
| Trade debtors | 243,165 | 81,012 | 203,812 | 24,034 | |
| Accrued | income and other debtors | 168,864 | 3,418,215 | 130,330 | 1,452,771 |
| VAT recoverable | 99,956 | 148,381 | 59,140 | 97,057 | |
| Prepayments | 177,778 | 172,084 | 126,808 | 136,486 | |
| 689,763 | 3,819,692 | 542,822 | 1,922,060 |
| 17. |
Creditors: amounts falling due wi |
thin one year | |||
|---|---|---|---|---|---|
| Group | Earl Mountbatten | Hospice | |||
| 2023 | 2022 | 2023 | 2022 | ||
| E | E | E | E | ||
| Trade creditors | 447,381 | 556,061 | 246,376 | 258,256 | |
| Deferred | income | 69,718 | 69,718 | 69,718 | 69,718 |
| Other creditors and accruals | 1,779,497 | 903,667 | 613,781 | 268,999 | |
| Amounts | due to group entities | 9,074 | |||
| 2,296,596 | 1,529,446 | 938,949 | 596,973 |
| Group | Earl Mountbatten | Hospice | |||||
|---|---|---|---|---|---|---|---|
| 2023 | 2022 | 2023 | 2022 | ||||
| E | E | E | E | ||||
| Balance | at the beginning ofthe year |
69,718 | 623,041 | 69,718 | 318,041 | ||
| Amount | released | to income | in the year | (553,323) | (248,323) | ||
| Amount | deferred | m the year | |||||
| Balance | at the end ofthe year | 69,718 | 69,718 | 69,718 | 69,718 |
| 20.a) Analysis ofgroup net assets between |
funds - 2023 | |||
|---|---|---|---|---|
| General | Designated | Restricted | Total | |
| unrestricted | funds | funds | funds | |
| E | E | E | E | |
| Tangible fixed assets | 372,201 | 9,020,915 | 2,299,930 | 11,693,046 |
| Investments | 31,629 | 31,629 | ||
| Net current assets | 5,618,635 | 552,520 | 1,115,804 | 7,286,959 |
| Net assets atthe end ofthe year | 6,022,465 | 9,573,435 | 3,415,734 | 19,011,634 |
| 20.a) Analysis ofgroup net assets between |
funds -2022 |
|||
|---|---|---|---|---|
| General | Designated | Restricted | Total | |
| unrestricted | funds | funds | funds | |
| E | E | E | E | |
| Tangible fixed assets | 368,040 | 9,020,915 | 2,329,918 | 11,718,873 |
| Investments | 7,310,840 | 500,000 | 7,810,840 | |
| Net current assets | 2,186,351 | 52,520 | 1,130,587 | 3,369,458 |
| Net assets atthe end ofthe year | 9,865,231 | 9,573,435 | 3,460,505 | 22,899,171 |
| 21.a) Mov | e | ment in funds |
- 2023 | ||||||
|---|---|---|---|---|---|---|---|---|---|
| At 1 Apnl | Gain on | At 31 | |||||||
| 2022 | Income | Expenditure | revaluations | Transfers | March 2023 | ||||
| E | E | E | E | E | E | ||||
| Restricted funds | |||||||||
| Capital funds | |||||||||
| John Cheverton estate |
fixed | ||||||||
| asset fund | 74,274 | (29,988) | 44,286 | ||||||
| Fixed Asset Fund | 2,255,644 | 2,255,644 | |||||||
| Revenue funds | |||||||||
| Community equipment |
2,678 | (2,678) | |||||||
| Clinical Co-ordination | Centre | 192,057 | (150,844) | 41,213 | |||||
| iBCF | 97,227 | 80,000 | (143,223) | 34,004 | |||||
| Kelly donation | 505 | 505 | |||||||
| Young adult services | 56,584 | (33,875) | 22,709 | ||||||
| DC clinical teaching post | 15,171 | (15,171) | |||||||
| NHS CCG - CQUINs | 39,038 | 39,038 | |||||||
| KissyPuppy restricted |
fund | 341,513 | 113,591 | (55,524) | 399,580 | ||||
| Advanced communication |
4,651 | (903) | 3,748 | ||||||
| MND Clinic | 9,451 | (2,524) | 6,927 | ||||||
| Responsible communities |
65,075 | (65,075) | |||||||
| Mountbatten young |
adults | 5,114 | (2,645) | 2,469 | |||||
| Barclays donation | 75,276 | (8,998) | 66,278 | ||||||
| Ward Furniture | 4,616 | (3,604) | 1,012 | ||||||
| Oak Garden Decking |
5,500 | (5,500) | |||||||
| Butterfly &Chelsea Garden | |||||||||
| Maintenance | 5,000 | (5,000) | |||||||
| Bladder Scanners | 8,000 | (917) | 7,083 | ||||||
| Hoist Pods for IPU | 4,560 | (880) | 3,680 | ||||||
| Essential Equipment |
for patient | ||||||||
| Care | 4,618 | 2,200 | (2,555) | 4,263 | |||||
| Gen Don-Community | 12,681 | (12,681) | |||||||
| Gen Don-Lymphoedema | 100 | (100) | |||||||
| Donations for Staff | 703 | (703) | |||||||
| JC Pool Vehicle Fund | 250,000 | 250,000 | |||||||
| Daisy Rich Trust | 1,000 | 1,000 | |||||||
| Hospital Saturday Fund |
2,000 | 2,000 | |||||||
| Other restricted funds |
8,676 | 1,011 | (342) | 9,345 | |||||
| Total restricted funds |
EMH | 3,221,019 | 517,495 | (543,730) | 3,194,784 |
| 21 | .a) M | o | veme | nt in fund |
s —2023 (cont.) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| At 31 | |||||||||||
| At 1 April | Gain on | March | |||||||||
| 2022 | Income | Expenditure | revaluations | Transfers | 2023 | ||||||
| E | E | E | E | E | E | ||||||
| Restricted funds - | CMH | ||||||||||
| NHSE | 98,870 | (27,070) | 71,800 | ||||||||
| Other | 140,616 | 81,437 | (72,903) | 149,150 | |||||||
| Total restricted funds | 3,460,505 | 598,932 | (643,703) | 3,415,734 | |||||||
| Unrestricted | funds | -EMH | |||||||||
| Designated | funds: | ||||||||||
| Fixed Asset | Fund | 9,073,435 | 9,073,435 | ||||||||
| Total designated | funds | - EMH | 9,073,435 | 9,073,435 | |||||||
| Designated | funds | - CMH | 500,000 | 500,000 | |||||||
| Total designated | funds | 9,573,435 | 9,573,435 | ||||||||
| General funds —EMH group | 5,957,898 | 7,275,552 | (9,749,624) | (319,870) | 3,163,956 | ||||||
| General funds —CMH group | 3,907,333 | 7,289,486 | (8,237,180) | (101,130) | 2,858,509 | ||||||
| Total unrestricted | funds | 19,438,666 | 14,565,038 | (17,986,804) | (421,000) | 15,595,900 | |||||
| Total funds | - EMH | 18,252,351 | 7,793,047 | (10,293,354) | (319,870) | 15,432,174 | |||||
| Total funds | - CMH | 4,646,820 | 7,370,923 | (8,337,153) | (101,130) | 3,579,460 | |||||
| Total funds | 22,899,171 | 15,163,970 | (18,630,507) | (421,000) | 19,011,634 |
| 21.b) Movemen |
t | in funds | - 2022 | ||||||
|---|---|---|---|---|---|---|---|---|---|
| At 1April | Gain on | At 31March | |||||||
| 2021 | Income | Expenditure | revaluation | 2022 | |||||
| E | E | E | E | E | |||||
| Restricted funds | |||||||||
| Capital funds | |||||||||
| John Cheverton estate |
fixed asset fund | 111,576 | (37,302) | 74,274 | |||||
| Fixed Asset Fund | 2,255,644 | 2,255,644 | |||||||
| Revenuefunds | |||||||||
| Community equipment |
12,475 | (9,797) | 2,678 | ||||||
| Clinical Co-ordination | Centre | 333,521 | (141,464) | 192,057 | |||||
| iBCF | 159,566 | 73,333 | (135,672) | 97,227 | |||||
| Kelly donation | 505 | 505 | |||||||
| Young adult services | 68,967 | 20,000 | (32,383) | 56,584 | |||||
| DC clinical teachmg post | 13,246 | (13,2461 | |||||||
| NHS CCG -CQUINs | 41,139 | (41,1391 | |||||||
| Hospital discharge co-ordinator | grant | 1 | (1) | ||||||
| KissyPuppy restncted |
fund | 269,148 | 100,810 | (28,445) | 341,513 | ||||
| Advanced communication |
4,651 | 4,651 | |||||||
| MND Clinic | 12,205 | (2,754) | 9,451 | ||||||
| Responsible communities |
66,750 | (1,675) | 65,075 | ||||||
| Mountbatten young |
adults | 5,144 | (30) | 5,114 | |||||
| Barclays donation | 92,156 | (16,880) | 75,276 | ||||||
| NHSE | 1,439,619 | (1,439,619) | |||||||
| Ward Furniture | 8,707 | (4,091) | 4,616 | ||||||
| Education Fund |
4,215 | (4,215) | |||||||
| Oak Garden Decking |
5,500 | 5,500 | |||||||
| Butterfly &Chelsea Garden | |||||||||
| Maintenance | 5,000 | 5,000 | |||||||
| Online Bereavement | support | 2,584 | (2,584) | ||||||
| Infection Control Salary Costs | 14,366 | (14,366) | |||||||
| Bladder Scanners | 9,000 | (1,000) | 8,000 | ||||||
| Hoist Pods for IPU | 5,520 | (960) | 4,560 | ||||||
| Essential Equipment |
For patient | Care | 4,954 | (336) | 4,618 | ||||
| SPOC/Palliative Care |
Hub | 47,593 | (47,593) | ||||||
| Music Therapy | 3,000 | (3,000) | |||||||
| Rodwell donation | 250,000 | (250,000) | |||||||
| Other restricted funds |
8,211 | 13,371 | (12,906) | 8,676 | |||||
| Total restricted funds |
EMH | 3,400,520 | 2,601,957 | (2,241,458) | 3,221,019 |
| 21.b) Move | ment |
in funds —2022 | (cont.) | ||||
|---|---|---|---|---|---|---|---|
| At 31 | |||||||
| At 1April | Gain on | March | |||||
| 2021 | Income | Expenditure | revaluation | 2022 | |||
| 6 | E | 6 | E | 6 | |||
| Restricted funds - | CMH | ||||||
| NHSE | 2,267,249 | (2,168,379) | 98,870 | ||||
| Other | 131,934 | 120,398 | (111,716) | 140,616 | |||
| Total restricted funds |
3,460,505 | 4,449,604 | (4,521,553) | 3,460,505 | |||
| Unrestricted | funds | -EMH | |||||
| Designated | funds: | ||||||
| Fixed Asset | Fund | 9,073,435 | 9,073,435 | ||||
| Total designated funds - EMH |
9,073,435 | 9,073,435 | |||||
| Designated | funds | - CMH | 500,000 | 500,000 | |||
| Total designated funds |
9,573,435 | 9,573,435 | |||||
| General funds —EMH group | 5,393,484 | 7,534,944 | (7,095,184) | 124,654 | 5,957,898 | ||
| General funds —CMH group | 1,487,746 | 7,321,656 | (5,062,616) | 160,547 | 3,907,333 | ||
| Total unrestricted | funds | 16,454,665 | 14,856,600 | (12,157,800) | 285,201 | 19,438,666 | |
| Total funds | - EMH | 17,867,439 | 9,596,900 | (9,336,642) | 124,654 | 18,252,351 | |
| Total funds | - CMH | 2,119,680 | 9,709,304 | (7,342,711) | 160,547 | 4,646,820 | |
| Total funds | 19,987,119 | 19,306,204 | (16,679,353) | 285,201 | 22,899,171 |
| 2023 | 2022 | |||||||
|---|---|---|---|---|---|---|---|---|
| E | E | |||||||
| Net (expenditure)/income for the reporting |
period | (3,887,537) | 2,912,052 | |||||
| (as per the statement | offinancial activities) | |||||||
| Depreciation charges |
387,012 | 311,608 | ||||||
| Profit on disposals | offixed assets | (13,594) | ||||||
| (Gains)/losses on investments |
421,000 | (285,092) | ||||||
| Dividends, interest |
and rent | from investments | (197,097) | (138,425) | ||||
| (Increase)/decrease | in stocks | (7,369) | 1,205 | |||||
| Decrease/(increase) | in debtors | 3,129,929 | (2,559,546) | |||||
| Increase/(Decrease) | in creditors | 767,150 | (579,672) | |||||
| Net cash (used in)/provided | by operating | activities | 613,088 | (351,464) | ||||
| Analysis of cash and | «ash equivalents | |||||||
| 2023 | 2022 | |||||||
| E | E | |||||||
| Cash in hand |
8,884,194 | 1,076,983 | ||||||
| Analysis ofchanges | in net debt | |||||||
| 1 April | Cash flows | 31March | ||||||
| 2022 | 2023 | |||||||
| E | E | |||||||
| Cash in hand | 1,076,983 | 7,807,211 | 8,884,194 |
| Group | Earl Mountbatten | Hospice | ||||
|---|---|---|---|---|---|---|
| 2023 | 2022 | 2023 | 2022 | |||
| E | E | E | E | |||
| Less | than one year | 347,398 | 306,275 | 156,898 | 160,441 | |
| One | to five years | 1,276,558 | 805,333 | 593,725 | 382,667 | |
| Over | five years | 784,117 | 11,250 | 355,200 | ||
| 2,048,073 | 1,122,858 | 1,105,823 | 543,108 |